Get started
Author

Piero Maria Stefani

Observed names: P M Stefani, P. M. Stefani, P. Stefani, P.M. Stefani, PIERO M. STEFANI, PIERO MARIA STEFANI, Piero M Stefani, Piero M. Stefani, Piero Stefani, Piero Maria Stefani, Pietro Maria Stefani, Stefani Piero Maria, Stefani, Piero Maria
Observed institutions: University of Udine, University of Padua, Universität Greifswald, University of Catania, AULSS 2 Marca Trevigiana, Istituto di Ematologia di Bologna, Ca' Foncello Hospital, Azienda Ospedale - Università Padova, University of Genoa, University of Bologna
ORCID: 0000-0003-2937-851X
Observed ORCID: 0000-0003-2937-851X
OpenAlex ID: A5073971614
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
2003 · Bruno Girolami, Paolo Prandoni, et al. · Blood · 276
PDF
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
2017 · Corrado Girmenia, Alice Bertaina, et al. · Clinical Infectious Diseases · 176
PDF
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
2011 · Giuseppe Visani, Lara Malerba, et al. · Blood · 148
PDF
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
2020 · Carlo Visco, Alice Di Rocco, et al. · Leukemia · 110
PDF
Heparin-induced thrombocytopenia.
2000 · F Fabris, G Luzzatto, et al. · PubMed · 87
Antithrombotic Drugs in the Primary Medical Management of Intermittent Claudication: A Meta-analysis
1999 · Enrico Bernardi, Martin Prins, et al. · Thrombosis and Haemostasis · 57
The prognostic value of positron emission tomography performed after two courses ( INTERIM‐PET ) of standard therapy on treatment outcome in early stage H odgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL)
2015 · Luigi Rigacci, Benedetta Puccini, et al. · American Journal of Hematology · 50
PDF
Short-Term Thalidomide Incorporated Into Double Autologous Stem-Cell Transplantation Improves Outcomes in Comparison With Double Autotransplantation for Multiple Myeloma
2009 · Michele Cavo, Francesco Di Raimondo, et al. · Journal of Clinical Oncology · 50
Advanced mast cell disease: an Italian Hematological Multicenter experience
2008 · Livio Pagano, Caterina Giovanna Valentini, et al. · International Journal of Hematology · 49
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse
2022 · Chiara Rusconi, Chan Y. Cheah, et al. · Blood · 48
PDF
Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma
2014 · Giuseppe Visani, Pietro Maria Stefani, et al. · Blood · 48
PDF
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial
2020 · Marco Ladetto, Sergio Cortelazzo, et al. · The Lancet Haematology · 44
PDF
Primary pancreatic lymphoma: Clinical presentation, diagnosis, treatment, and outcome
2020 · Davide Facchinelli, Sokol Sina, et al. · European Journal Of Haematology · 34
MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34+ Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia
2020 · Gaia Spinetti, Elena Sangalli, et al. · Diabetes Care · 32
Intensive short‐term chemotherapy regimen induces high remission rate (over 90%) and event‐free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia
2011 · Giuseppe Todeschini, Massimiliano Bonifacio, et al. · American Journal of Hematology · 32
PDF
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma
2022 · Simone Ferrero, Daniele Grimaldi, et al. · Blood · 31
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi
2018 · Jacopo Olivieri, Federico Mosna, et al. · Transplantation and Cellular Therapy · 30
PDF
Measurement of serum monoclonal components: comparison between densitometry and capillary zone electrophoresis
2006 · Michele Mussap, Francesco Pietrogrande, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 27
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study
2024 · Chiara Malinverni, Andrea Bernardelli, et al. · Blood · 20
MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma
2014 · L. Toffolatti, E. Scquizzato, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 20
Impact of Rituximab Maintenance Added to Ibrutinib-Containing Regimens with and without ASCT in Younger, Previously Untreated MCL Patients: An Analysis of the Triangle Data Embedded in the Multiply Project
2024 · Marco Ladetto, Katja Gutmair, et al. · Blood · 15
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience
2021 · Fulvio Massaro, Vincenzo Pavone, et al. · Hematological Oncology · 15
PDF
A Novel High Dose Chemotherapy Strategy with Bendamustine In Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: a Phase I-II Study on 44 Patients
2010 · Giuseppe Visani, Lara Malerba, et al. · Blood · 14
Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation
2008 · Michele Gottardi, Cristina Danesin, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 14
Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi
2023 · Maria E. Nizzoli, Martina Manni, et al. · Hematological Oncology · 12
Works count: 84
Citation count: 1,613
H-index: 20
I10-index: 31
Year
Topic
Type